Invention Grant
US07807350B2 Methods for predicting irinotecan toxicity 有权
预测伊立替康毒性的方法

Methods for predicting irinotecan toxicity
Abstract:
The present invention concerns the methods and compositions for evaluating the risk of ironotecan toxicity in a cancer patient based on the genotype of the patient at position −3156 of the UGT1A1 gene or at any position in linkage disequilibrium with the −3156 variant.
Public/Granted literature
Information query
Patent Agency Ranking
0/0